← capex_spike (all companies) · SGMO (all signals) · all methodology
capex_spike on SANGAMO THERAPEUTICS, INC (SGMO)
SIC 2836 — Biological Products, (No Diagnostic Substances) · CIK 1001233 · default direction: short
Definition
Fires on >50% YoY capex increase. Captures aggressive reinvestment phases — often precedes value destruction in mature industries.
Every time the signal fired on SGMO
| FY | Filing date | Event date | 1d | 5d | 20d | 60d | 252d |
|---|---|---|---|---|---|---|---|
| FY2021 | 2022-02-24 | 2022-02-24 | +3.33% | -1.58% | +3.68% | -27.50% | -48.16% |
| FY2018 | 2019-03-01 | 2019-03-01 | +0.40% | -3.48% | -5.07% | -4.18% | -15.42% |
| FY2017 | 2018-03-01 | 2018-03-01 | +3.19% | +8.51% | -19.15% | -33.62% | -57.06% |
| FY2015 | 2016-02-18 | 2016-02-18 | +0.00% | -3.95% | -3.20% | +14.66% | -24.81% |
| FY2011 | 2012-02-23 | 2012-02-23 | -1.25% | -5.90% | -18.25% | -22.18% | +56.89% |
Forward returns are stock returns from event date (next trading day after filing). Sign is raw stock direction; the trade direction is in the calibration table below.
Universe-wide calibration (this signal across all companies)
| Horizon | n events | Gross stock ret | Hit rate | Trade dir | Net PnL | Cost (bps) | r/σ net |
|---|---|---|---|---|---|---|---|
| 1d | 2,295 | +0.01% | +43.27% | short | -0.06% | 32 | -0.01 |
| 5d | 2,292 | -0.85% | +41.88% | short | +0.74% | 33 | +0.06 |
| 20d | 2,258 | -1.91% | +41.67% | short | +2.05% | 36 | +0.10 |
| 60d | 2,127 | +0.65% | +44.01% | short | -0.78% | 47 | -0.02 |
| 252d | 2,092 | +14.03% | +44.93% | short | -14.91% | 97 | -0.09 |
Net PnL is direction × stock return − round-trip execution cost (5 bps half-spread + ADV-tiered borrow). See capex_spike methodology for the full audit.